Rentschler Biotechnologie GmbH has opened a U.S.based sales office in New Providence, NJ. As a well-established, full-service biopharmaceutical CMO, Rentschler is expanding its sales efforts to improve support for its North American clients.
Rentschler's manufacturing and fill & finish services at the company's facilities in Laupheim, Germany, are carried out in accordance with international GxP standards.
The company is expanding the capacity of its technological and operative sites, allowing the production of material for both clinical studies and commercial scale.
The addition of fermenter suites has strengthened the company's biotechnology business in custom manufacturing services from cell line development to large-scale cGMP production, registration of drugs and fill & finish.
Keywords : Rentschler Biotechnologie Germany Biomanufacturing Fill & finish USA Expansion
